Navigation Links
Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
Date:9/25/2008

tes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs approximately 26,550 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit http://www.novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
2. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
4. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
5. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
6. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
7. DSMB Again Supports Continuation of Alimera Sciences Phase 3 Clinical Trial of Iluvien(TM) for the Treatment of DME
8. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
9. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
10. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
11. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... 2015 La solución de ... cuidado al paciente a lo ... Royal Philips  (NYSE: PHG, AEX: PHIA) ... Cardiovascular , un sistema web de gestión de imágenes ... y compartir imágenes cardiovasculares e información en cualquier momento, ...
(Date:8/28/2015)... 2015  CytomX Therapeutics, Inc., a biopharmaceutical company developing ... the filing of a registration statement on Form S-1 ... to a proposed initial public offering of its common ... the price range for the offering have not yet ... under the symbol "CTMX" on the NASDAQ Global Market. ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "12th ... and Production" report to their offering. ... of Biopharmaceutical Manufacturing Capacity and Production is the ... manufacturing organizations, current and projected future capacity and ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3CytomX Files Registration Statement for Proposed Initial Public Offering 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... KINNELON, N.J., Sept. 8, 2011 Life Recovery Systems ... three-year agreement by Premier Purchasing Partners, LP, the group ... the ThermoSuit System available by contract to its more ... award, LRS,s first GPO contract, Robert Neary, LRS Director ...
... Elusys Therapeutics, Inc. (Elusys), a  biopharmaceutical company developing ... awarded the first U.S. Government contract to develop ... use via intramuscular injection (IM). The five year ... multiple animal efficacy studies as well as human ...
Cached Medicine Technology:Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 2Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 3Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 2Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 3
(Date:8/31/2015)... ... 31, 2015 , ... On Saturday, July 11, 2015, during the annual New ... City, NYSATA was proud to recognize Dr. Merritt F. Spear as the 2015 recipient ... named after long-time NYSATA member and Ithaca College athletic trainer and educator, is considered ...
(Date:8/31/2015)... ... 31, 2015 , ... All birth control methods work best if used correctly ... among birth control methods. Moreover, no-scalpel vasectomy has many proven advantages with a lower ... vasectomy done because they are afraid of complications. , One Stop Medical Center ...
(Date:8/31/2015)... Charleston, SC (PRWEB) , ... August 31, 2015 , ... ... is making it their business to help small businesses operate as efficiently and cost ... They've already made an impact in their first year of operation – and ...
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... Avid collector ... and the Doors Shrine Auditorium concert posters. This hand colored artwork is one of ... 23 in Los Angles. Hawley states, "When the doors played the Shrine, the ...
(Date:8/30/2015)... ... August 31, 2015 , ... Intellitec Solutions, based ... & Expo October 5th & 6th in San Antonio, TX. Dedicated to bringing ... industry professionals from all over the country come to share the latest and ...
Breaking Medicine News(10 mins):Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:One Stop Medical Center of Twin Cities Achieves Zero Failure Rate and Infection Rate in No Scalpel Vasectomy 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 3Health News:Intellitec Solutions to feature Microsoft Dynamics GP at AHCA/NCAL 66th Annual Convention & Expo 2
... , FRIDAY, Dec. 30 (HealthDay News) -- New research suggests ... cause, multiple sclerosis also damages the part of the brain ... "The thalamus is a central area that relates to the ... study co-author Khader Hasan, an associate professor at University of ...
... , FRIDAY, Dec. 30 (HealthDay News) --,Binge drinking ... study. Researchers looked at 208 unmarried heterosexual dating couples ... five days a week. At least one member of each ... had dated for a minimum of three months and an ...
... There are many ways to prevent spreading germs and disease, ... one of the most important: proper hand-washing. This ... get together for parties and other celebrations, researchers at the ... is the single most effective way to prevent the spread ...
... Researchers have identified six risk factors linked to blindness after ... ischemic optic neuropathy, or ION, the complication occurs when the ... estimated to occur in as many as one in 1,000 ... at any age, according to researchers. For the new ...
... (December 29, 2011) Two recent studies by Van ... more complete understanding of distinct kidney cancer subtypes, which could ... published in Cancer Cell led by Kyle Furge, ... understanding of the biology of Type 2 papillary renal cell ...
... By E.J. Mundell HealthDay Reporter , THURSDAY, Dec. ... in 2011, the ongoing debate over the legality of the new ... case now set to go to the U.S. Supreme Court early ... Care Act , which President Obama signed into law in 2010, ...
Cached Medicine News:Health News:Multiple Sclerosis May Cause Changes in Thalamus: Study 2Health News:Hand-Washing Key to Stopping Spread of Disease 2Health News:Risk Factors for Vision Loss After Spine Surgery Identified 2Health News:Van Andel Research Institute findings provide more complete picture of kidney cancer 2Health News:Health Care Reform Battle Tops Health News for 2011 2Health News:Health Care Reform Battle Tops Health News for 2011 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: